Search This Blog

Monday, March 2, 2020

Albireo Pharma EPS beats by $1.02, beats on revenue

Albireo Pharma (NASDAQ:ALBO): Q4 GAAP EPS of -$0.57 beats by $1.02.
Revenue of $6.43M (+1028.1% Y/Y) beats by $4.9M.
Press Release
https://seekingalpha.com/news/3547346-albireo-pharma-eps-beats-1_02-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)